197 related articles for article (PubMed ID: 17371270)
1. Impact of dietary amino acids and polyamines on intestinal carcinogenesis and chemoprevention in mouse models.
Gerner EW
Biochem Soc Trans; 2007 Apr; 35(Pt 2):322-5. PubMed ID: 17371270
[TBL] [Abstract][Full Text] [Related]
2. APC-dependent changes in expression of genes influencing polyamine metabolism, and consequences for gastrointestinal carcinogenesis, in the Min mouse.
Erdman SH; Ignatenko NA; Powell MB; Blohm-Mangone KA; Holubec H; Guillén-Rodriguez JM; Gerner EW
Carcinogenesis; 1999 Sep; 20(9):1709-13. PubMed ID: 10469614
[TBL] [Abstract][Full Text] [Related]
3. Dietary putrescine reduces the intestinal anticarcinogenic activity of sulindac in a murine model of familial adenomatous polyposis.
Ignatenko NA; Besselsen DG; Roy UK; Stringer DE; Blohm-Mangone KA; Padilla-Torres JL; Guillen-R JM; Gerner EW
Nutr Cancer; 2006; 56(2):172-81. PubMed ID: 17474863
[TBL] [Abstract][Full Text] [Related]
4. Combination chemoprevention of intestinal carcinogenesis in a murine model of familial adenomatous polyposis.
Ignatenko NA; Besselsen DG; Stringer DE; Blohm-Mangone KA; Cui H; Gerner EW
Nutr Cancer; 2008; 60 Suppl 1():30-5. PubMed ID: 19003578
[TBL] [Abstract][Full Text] [Related]
5. Role of polyamines in arginine-dependent colon carcinogenesis in Apc(Min) (/+) mice.
Yerushalmi HF; Besselsen DG; Ignatenko NA; Blohm-Mangone KA; Padilla-Torres JL; Stringer DE; Guillen JM; Holubec H; Payne CM; Gerner EW
Mol Carcinog; 2006 Oct; 45(10):764-73. PubMed ID: 16705737
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.
Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF
Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490
[TBL] [Abstract][Full Text] [Related]
7. Cancer pharmacoprevention: Targeting polyamine metabolism to manage risk factors for colon cancer.
Gerner EW; Bruckheimer E; Cohen A
J Biol Chem; 2018 Nov; 293(48):18770-18778. PubMed ID: 30355737
[TBL] [Abstract][Full Text] [Related]
8. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.
Jacoby RF; Cole CE; Tutsch K; Newton MA; Kelloff G; Hawk ET; Lubet RA
Cancer Res; 2000 Apr; 60(7):1864-70. PubMed ID: 10766173
[TBL] [Abstract][Full Text] [Related]
9. Polyamines as mediators of APC-dependent intestinal carcinogenesis and cancer chemoprevention.
Rial NS; Meyskens FL; Gerner EW
Essays Biochem; 2009 Nov; 46():111-24. PubMed ID: 20095973
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse.
Ritland SR; Leighton JA; Hirsch RE; Morrow JD; Weaver AL; Gendler SJ
Clin Cancer Res; 1999 Apr; 5(4):855-63. PubMed ID: 10213222
[TBL] [Abstract][Full Text] [Related]
11. The role of NO synthases in arginine-dependent small intestinal and colonic carcinogenesis.
Yerushalmi HF; Besselsen DG; Ignatenko NA; Blohm-Mangone KA; Padilla-Torres JL; Stringer DE; Cui H; Holubec H; Payne CM; Gerner EW
Mol Carcinog; 2006 Feb; 45(2):93-105. PubMed ID: 16329147
[TBL] [Abstract][Full Text] [Related]
12. R-flurbiprofen chemoprevention and treatment of intestinal adenomas in the APC(Min)/+ mouse model: implications for prophylaxis and treatment of colon cancer.
Wechter WJ; Kantoci D; Murray ED; Quiggle DD; Leipold DD; Gibson KM; McCracken JD
Cancer Res; 1997 Oct; 57(19):4316-24. PubMed ID: 9331093
[TBL] [Abstract][Full Text] [Related]
13. Chemopreventive agents inhibit aberrant proliferation of the aneuploid phenotype in a colon epithelial cell line established from Apc 1638N [+/-] mouse.
Katdare M; Kopelovich L; Telang N
Ann N Y Acad Sci; 2001 Dec; 952():169-74. PubMed ID: 11795437
[TBL] [Abstract][Full Text] [Related]
14. Rationale for, and design of, a clinical trial targeting polyamine metabolism for colon cancer chemoprevention.
Gerner EW; Meyskens FL; Goldschmid S; Lance P; Pelot D
Amino Acids; 2007 Aug; 33(2):189-95. PubMed ID: 17396214
[TBL] [Abstract][Full Text] [Related]
15. Phospho-sulindac (OXT-328) combined with difluoromethylornithine prevents colon cancer in mice.
Mackenzie GG; Ouyang N; Xie G; Vrankova K; Huang L; Sun Y; Komninou D; Kopelovich L; Rigas B
Cancer Prev Res (Phila); 2011 Jul; 4(7):1052-60. PubMed ID: 21464038
[TBL] [Abstract][Full Text] [Related]
16. Risk and risk reduction involving arginine intake and meat consumption in colorectal tumorigenesis and survival.
Zell JA; Ignatenko NA; Yerushalmi HF; Ziogas A; Besselsen DG; Gerner EW; Anton-Culver H
Int J Cancer; 2007 Feb; 120(3):459-68. PubMed ID: 17096347
[TBL] [Abstract][Full Text] [Related]
17. Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
Meyskens FL; Gerner EW
Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725
[TBL] [Abstract][Full Text] [Related]
18. Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse.
Song J; Medline A; Mason JB; Gallinger S; Kim YI
Cancer Res; 2000 Oct; 60(19):5434-40. PubMed ID: 11034085
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of intestinal tumorigenesis by nabumetone: induction of apoptosis and Bcl-2 downregulation.
Roy HK; Karoski WJ; Ratashak A; Smyrk TC
Br J Cancer; 2001 May; 84(10):1412-6. PubMed ID: 11355956
[TBL] [Abstract][Full Text] [Related]
20. Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis.
Perkins S; Verschoyle RD; Hill K; Parveen I; Threadgill MD; Sharma RA; Williams ML; Steward WP; Gescher AJ
Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):535-40. PubMed ID: 12050094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]